Insulet Partners with Glooko as its Preferred Data Management Partner for OmniPod Patients and Healthcare Providers

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced it has partnered with Glooko1, the leader in diabetes management mobile and web applications, to provide U.S. OmniPod patients and healthcare providers a new data management system named "Insulet Provided Glooko". This new system is available today to patients who use the OmniPod System, as well as healthcare professionals who care for these patients."A critical component of diabetes management is the ability for patients, as well as their healthcare providers, to see a complete picture of their health," said Patrick Sullivan, President and Chief Executive Officer. "Having the ability to track and analyze information about a patient's insulin data, in combination with blood glucose levels, diet and exercise data, allows patients and their care teams to optimize and improve their healthcare management. We are pleased to partner with Glooko as Insulet's preferred data management partner and are thrilled to offer Glooko's award winning diabetes management platform with our OmniPod System."